A MULTI-CENTER RANDOMIZED STUDY TO COMPARE THE EFFECTS OF OVARIAN ABLATION WITH ZOLADEX DEPOT IN PREMENOPAUSAL AND PERIMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER

被引：3
|
作者：
TYRRELL, C [1 ]
机构：
[1] PLYMOUTH GEN HOSP,DEPT RADIOTHERAPY & ONCOL,PLYMOUTH,DEVON,ENGLAND
来源：
HORMONE RESEARCH | 1989年 / 32卷
关键词：
D O I：
10.1159/000181350
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：218 / 220
页数：3
相关论文
共 50 条
  • [31] Multi-center randomized study of pembrolizumab/carboplatin versus carboplatin alone in patients with chest wall disease from breast cancer: TBCRC 044.
    Vidula, Neelima
    Nanda, Rita
    Miller, Kathy D.
    Emens, Leisha A.
    Pohlmann, Paula R.
    Abramson, Vandana G.
    Park, Ben Ho
    Liu, Minetta C.
    Goga, Andrei
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [32] Open, multi-center, phase IV study to assess the efficacy and tolerability of triptorelin in Taiwanese patients with advanced prostate cancer
    Kao, Chien-Chang
    Chang, Yen-Hwa
    Wu, Tony
    Sun, Guang-Huan
    Yu, Dah-Shyong
    Chang, Sun-Yran
    Cha, Tai-Lung
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2012, 75 (06) : 255 - 261
  • [33] Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study
    R. Fernandes
    S. Mazzarello
    A. A. Joy
    G. R. Pond
    J. Hilton
    M. F. K. Ibrahim
    C. Canil
    M. Ong
    C. Stober
    L. Vandermeer
    B. Hutton
    M. da Costa
    S. Damaraju
    Mark Clemons
    Supportive Care in Cancer, 2018, 26 : 3073 - 3081
  • [34] Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study
    Fernandes, R.
    Mazzarello, S.
    Joy, A. A.
    Pond, G. R.
    Hilton, J.
    Ibrahim, M. F. K.
    Canil, C.
    Ong, M.
    Stober, C.
    Vandermeer, L.
    Hutton, B.
    da Costa, M.
    Damaraju, S.
    Clemons, Mark
    SUPPORTIVE CARE IN CANCER, 2018, 26 (09) : 3073 - 3081
  • [35] A multi-center phase II study of the cryptophycin analogue LY355703 in patients with platinum-resistant ovarian cancer
    D'Agostino, G.
    Del Campo, J.
    Mellado, B.
    Izquierdo, M. A.
    Minarik, T.
    Cirri, L.
    Marini, L.
    Crucitta, E.
    La Torre, I.
    Perez-Gracia, L.
    Scambia, G.
    ANNALS OF ONCOLOGY, 2005, 16 : 152 - 153
  • [36] RANDOMIZED TRIAL OF CHEMOTHERAPY VERSUS ENDOCRINE THERAPY IN PATIENTS PRESENTING WITH LOCALLY ADVANCED BREAST-CANCER (A PILOT-STUDY)
    GAZET, JC
    FORD, HT
    COOMBES, RC
    BRITISH JOURNAL OF CANCER, 1991, 63 (02) : 279 - 282
  • [37] Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study
    Mitsuo Terada
    Naoto Kondo
    Yumi Wanifuchi-Endo
    Takashi Fujita
    Tomoko Asano
    Tomoka Hisada
    Yasuaki Uemoto
    Natsumi Akiko Kato
    Hiroshi Yamanaka
    Keiko Sugiura
    Asaka Mita
    Eriko Wada
    Kanako Takahashi
    Ryo Saito
    Tatsuya Yoshioka
    Breast Cancer Research and Treatment, 2022, 195 : 311 - 323
  • [38] Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study
    Terada, Mitsuo
    Kondo, Naoto
    Wanifuchi-Endo, Yumi
    Fujita, Takashi
    Asano, Tomoko
    Hisada, Tomoka
    Uemoto, Yasuaki
    Kato, Akiko
    Yamanaka, Natsumi
    Sugiura, Hiroshi
    Mita, Keiko
    Wada, Asaka
    Takahashi, Eriko
    Saito, Kanako
    Yoshioka, Ryo
    Toyama, Tatsuya
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 195 (03) : 311 - 323
  • [39] A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations
    Kwag, Eunbin
    Kim, Soo-Dam
    Shin, Seong-Hoon
    Oak, Chulho
    Park, So-Jung
    Choi, Jun-Yong
    Hoon Yoon, Seong
    Kang, In-Cheol
    Jeong, Mi-Kyung
    Woo Lee, Hyun
    Bang, Sun-Hwi
    Son, Ji Woong
    Lee, Sanghun
    Kim, Seung Joon
    Yoo, Hwa-Seung
    INTEGRATIVE CANCER THERAPIES, 2024, 23
  • [40] A multi-center randomized phase II study of nivolumab in combination with gemcitabine/cisplatin or ipilimumab as first line therapy for patients with advanced unresectable biliary tract cancer.
    Sahai, Vaibhav
    Griffith, Kent A.
    Beg, Muhammad Shaalan
    Zalupski, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345